Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure

Kidney International

Volumn 53, Issue 5, 1998, Pages 1336-1342

  Stenvinkel, Peter ^a   Heimbürger, Olof ^b   Tuck, Catherine H ^b   Berglund, Lars ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Atherosclerosis; C reactive protein; Chronic renal failure; Inflammation; Lipoprotein(a); Malnutrition

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY COMPOSITION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; PRIORITY JOURNAL; UREMIA;

EID: 0031819896     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00880.x     Document Type: Article

References (36)

1. LINDNER A, CHARRA B, SHERRARD DJ, SCHRIHNER BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697-701, 1974
2. MA KW, GREENE EL, RAIJ L: Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 19:505-513, 1992
3. UTERMANN G, WEBER W: Protein composition of Lp(a) lipoprotein from human plasma. FEBS Lett 154:357-361, 1983
4. CRESSMAN MD, HHYKA RJ, PAGANINI EP, O'NEIL J, SKIBINSKI CI, HOFF HF: Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 86:475-482, 1992
5. ARMSTRONG VW, CREMER P, EBERLE E, MANKE A, SCHULZE F, WIELAND H, KREUZER H, SEIDEL D: The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis: Dependence on serum LDL levels. Atherosclerosis 62:249-257, 1986
6. DURRINGTON PN, ISHOLA M, HUNT L, ARROL S, BHATNAGER D: Apolipoprotein (a), A1 and B and parenteral history in men with early onset ischaemic heart disease. Lancet 1:1070-1073, 1988
7. BERGSTRÖM J, LINDHOLM B: Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare? Kidney Int 34(Suppl 40):S39-S50, 1993
8. KEANE WF, COLLINS AJ: Influence of co-morbidity on mortality and morbidity of hemodialysis patients. Am J Kidney Dis 24:1010-1018, 1994
9. LOWRIE EG, LEW NL: Death risk in hemodialysis patients: The predicitive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990
10. HEIMBÜRGER O, STENVINKEL P, BERGLUND L, TRANAEUS A, LINDHOLM B: Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose. Nephron 72:135-144, 1996
11. WANNER C, BARTENS W, WALZ G, NAUCK M, SCHOLLMEYER P: Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients. Nephrol Dial Transplant 10:75-81, 1995
12. YANG WS, KIM SB, MIN WK, PARK S, LEE MS, PARK JS: Atherogenic lipid profile and lipoprotein(a) in relation to serum albumin in haemodialysis patients. Nephrol Dial Transplant 10:1668-1671, 1994
13. KANG DH, YOON KI, LEE SW, KANG SW, CHOI KH, LEE HY, HAN DS: Impact of nutritional status on serum lipoprotein(a) concentrations in patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int 16(Suppl 1):S241-S245, 1996
14. KAYSEN GA, STEVENSON FT, DEPNER TA: Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 29:658-668, 1997
15. NOMA A, ABE A, MAEDA S, SEISHIMA M, MAKINO K, YANO Y, SHIMOKAWA K: Lp(a): An acute phase reactant? Chem Phys Lipids 67-68:411-417, 1994
16. KARIO K, MATSUO T, KOBAYASHI H, MATSUO M, ASADA R, KOIDE M: High lipoprotein(a) levels in chronic hemodialysis patients are closely related to acute phase reaction. Thromb Haemost 74:1020-1024, 1995
17. ZIMMERMAN J, HERRLINGER S, PRUY A, WANNER C: Mechanism of high serum lipoprotein(a) in hemodialysis patients. (abstract) J Am Soc Nephrol 8:260A, 1997
18. LOPES-VIRELIA MF, STONE P, ELNIS S, COLWEH JA: Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 23:882-884, 1977
19. FRIEDEWALD WT, LEVY RI, FREDRICKSON DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1977
20. KAMBOH MI, FERRELL RE, KOTTKE BA: Expressed hypervariable polymorphism of apolipoprotein (a). Am J Hum Genet 49:1063-1074, 1991
21. BAKER JP, DETSKY AS, WESSON DE, WOLMAN SL, STEWART S, WHITEWELL J, LANGER B, JEEJEEBHOY KN: Nutritional assessment: A comparison of clinical judgment and objective measurements. N Engl J Med 306:969-972, 1982
22. DETSKY AS, MCLAUGHLIN JR, BAKER JP, JOHNSION N, WHITTAKER S, MENDELSON RA, JEEJEEBHOY KN: What is subjective global assessment of nutritional status? J Parenter Enterol Nutr 33:650-653, 1987
23. ARNADOTTIR M, THYSELL H, NILSSON-EHLE P: Serum lipoprotein(a) is increased in moderate renal failure. Nephron 72:712-713, 1996
24. UTERMANN G, MENZEL HJ, KRAFT HG, DUBA HC, KEMMLER HG, SEITZ C: Lp(a) glycoprotein phenotypes; inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invst 80:458-465, 1987
25. KRONENBERG F, KÖNIG P, NEYER U, AUINGER M, PRIBASNIG A, LANG U, REITINGER J, PINTER G, UTERMANN G: Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory dialysis. J Am Soc Nephrol 6:110-120, 1995
26. TROMMSDORF M, KÖCHL S, LINGENHEL A, KRONENBERG F, DELPORT R, VERMAAK H, LEMMING L, KLALUSEN IC, GAERGEMAN O, UTERMANN G, KRAFT H-G: A pentanucleotide repeat polymorphism in the 5′ control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians. J Clin Invest 96:150-157, 1995
27. STENVINKEL P, BERGLUND L, HEIMBÜRGER O, PETTERSSON E, ALVESTRAND A: Lipoprotein(a) in nephrotic syndrome. Kidney Int 44:1116-1123, 1993
28. WANNER C, RADER D, BARTENS W, KRÄMER J, BREWER B, SCHOLLMFYER P, WIELAND H: Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome. Ann Intern Med 119:263-269, 1993
29. APPEL GB, BLUM CB, CHIEN S, KUNIS CL, APPEL AS: The hyperlipidemia of the nephrotic syndrome: Relation to plasma albumin concentration, oncotic pressure and viscocity. N Engl J Med 312:1544-1548, 1985
30. STENVINKEL P, BERGLUND L, ERICSSON S, ALVESTRAND A, ANGELIN B, ERIKSSON M: Low-density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome. Europ J Clin Invest 27:169-177, 1997
31. KRONENBERG F, KÖNIG P, LHOTTA K, ÖFNER K, SANDHOLZER C, MARGRFITER R, DOSCH E, UTERMAN G, DIEPLINGER H: Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation. Arteriscler Thromb 14:1399-1404, 1994
32. KOPPLE JD: Nutritional managment of nondialyzed patients with chronic renal failure, in Nutritional Managment of Renal Disease. edited by KOPPLE JD, MASSRY SG, Baltimore, William & Wilkins. 1996, pp 479-531
33. OURESHI AR, ALVESTRAND A, DANIFLSSON A, DIVINO-FILHO JC, GUTIERREZ A, LINDHOLM B, BERGSTRÖM J: Factors predicting malnutrition in hemodialysis patients. A cross-sectional study. Kidney Int 53:773-782, 1998
34. MAEDA S, ABE A, SESHLMA M, MAKINO K, NOMA A, KAWEDE M: Transient changes of serum lipoprotein (a) as an acute phase protein. Atherosclerosis 78:145-150, 1989
35. ZIMMERMAN J, PRUY A, HERRLINGER S, WANNER C: The atherogenic risk in hemodialysis patients is enhanced by inflammation. (abstract) J Am Soc Nephrol 8:215A, 1997
36. GAW A, BOERWINKLE E, COHEN JC, HOBBS HH: Comparative analysis of the apo(a) gene, apo(a) glycoprotein and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele in the apo(a) locus. J Clin Invest 93:2526-2534, 1994